Bruker (BRKRP) Payables (2010 - 2026)

Bruker has reported Payables for 17 years, with the latest figure at $269.1 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 10.02% year-over-year to $269.1 million; the trailing twelve-month figure through Mar 2026 stood at $269.1 million (up 10.02% YoY), and the FY2025 full-year result was $227.4 million, down 2.86% from the prior year.
• Payables for Q1 2026 stood at $269.1 million, up from $227.4 million in the prior quarter.
• The five-year high for Payables was $269.1 million in Q1 2026, with the low at $154.9 million in Q2 2022.
• Historically, Payables has averaged $204.2 million across 5 years, with a median of $199.1 million in 2024.
• Annual changes were most pronounced in 2024 — Payables rose 25.34% — and 2025, when it fell 18.95%.
• Bruker's Payables stood at $178.4 million in 2022, then gained by 13.62% to $202.7 million in 2023, then climbed by 15.49% to $234.1 million in 2024, then retreated by 2.86% to $227.4 million in 2025, then grew by 18.34% to $269.1 million in 2026.
• The last three Payables figures came in at $269.1 million (Q1 2026), $227.4 million (Q4 2025), and $184.4 million (Q3 2025), per Business Quant data.